Navigation Links
Thomson CompuMark Launches World's Most Comprehensive Trademark Search Offering for Pharmaceutical Brand Owners
Date:5/26/2010

BOSTON, May 26 /PRNewswire/ -- Thomson CompuMark, a Thomson Reuters business, today announced new, proprietary FDA drug sources in its Pharmaceutical XC Search, plus authentic FDA Phonetic Orthographic Computer Analyses (POCAs) of potential marks, both of which reduce the risk of pharmaceutical brand conflicts. This new content comprises the world's most comprehensive coverage of drug-related brands and helps companies protect their investment in creating, clearing and registering drug trademarks.  

"With so many drug names on the market, pharmaceutical brand owners face particularly complex challenges when developing new trademarks," said Martin Burke, group managing director of Thomson CompuMark. "Expanding the coverage of our industry-leading Pharmaceutical XC Search is just the latest example of how Thomson Reuters keeps brand owners, and the IP professionals who advise them, ahead of the curve, providing the most complete information to help them make better decisions and reduce their business risk."

Pharmaceutical XC Search offers:

  • Exclusive search coverage of Thomson Reuters Micromedex, including international and FDA-approved drugs, as well as the Natural Medicines Database, the gold standard for natural medicines product information
  • Additional FDA-recommended sources, including Drugs@FDA, AERS (Adverse Event Reporting System) and VAERS (Vaccine Adverse Event Reporting System) – important sources of brand names for which adverse events have been reported
  • An authentic FDA POCA of Thomson CompuMark's proprietary database featuring more than 90,000 drug names – the most extensive in the industry. Endorsed by the FDA, POCAs help clients identify potentially problematical names early in the clearance process, prior to FDA submission, by assessing the similarity of the mark in writing and speech, thereby reducing the risk of name rejection due to potential confusion
  • New Citation Matrix showing the incidence of use for researched marks across the sources searched, offering additional insight on trademark use.

For more information on Pharmaceutical XC Search, go to http://compumark.thomson.com/do/pharmaceutical.

About Thomson CompuMark

Thomson CompuMark, a part of Thomson Reuters, delivers comprehensive solutions for global trademark research and brand protection, powered by the most extensive trademark resources in the world. Widely recognized as the global industry leader, Thomson CompuMark currently serves 80 of the top 100 brand owners and many of the world's leading intellectual property law firms.

About Thomson Reuters

Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, healthcare and science and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs 55,000 people and operates in over 100 countries. For more information, go to www.thomsonreuters.com.


'/>"/>
SOURCE Thomson CompuMark
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Tablet PC Technology Helps Doctors and Patients Focus on Chemotherapy Side Effects, According to Thomson Healthcare Study
3. Berkery Noyes Represented The Thomson Corporation in the Sale of CenterWatch and New England Institutional Review Board to Jobson Medical Information
4. Thomson Healthcare Cancer Profiler Used in Study
5. Thomson Reuters Study Finds Sharp Increase in Use of Sleep Medications by Young Adults
6. General Practitioners Write Most Prescriptions for Mental Health Drugs, According to Study from Thomson Reuters and SAMHSA
7. University of Kansas Hospital Deploys NeoFax from Thomson Reuters for Electronic Neonatal Drug Dosing to Support Medication Safety
8. Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs
9. The University of Hong Kong Chooses ResearcherID By Thomson Reuters to Standardize Research Identifiers
10. Thomson Reuters Launches Pharmacy Intervention Solution for Hospital Pharmacists
11. Americans Losing Confidence in Their Ability to Access and Pay for Healthcare, According to Thomson Reuters Index
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of ... acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... p.m. (Eastern Daylight Time). As previously announced ... into a definitive merger agreement under which Jazz Pharmaceuticals ...
(Date:6/24/2016)... SOUTH SAN FRANCISCO, Calif. , June 24, ... GBT ), a biopharmaceutical company developing novel ... with significant unmet needs, today announced the closing ... 6,400,000 shares of common stock, at the public ... the shares in the offering were offered by ...
(Date:6/24/2016)... June 24, 2016 Dehaier Medical Systems Ltd. ... which develops, markets and sells medical devices and wearable ... signed a strategic cooperation agreement with Hongyuan Supply Chain ... Chain") on June 20, 2016, to develop Dehaier,s new ... cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s sales ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from PsychTests.com reveals that behind the tendency to set ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are recognized ... this recognition are considered among the top 2 percent of lawyers practicing within the ... this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, Burt ...
(Date:6/24/2016)... ... 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join ... wage raise to $12 an hour by 2020 and then adjusting it yearly to increase ... of the minimum wage, assure the wage floor does not erode again, and make future ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... is proud to recognize Dr. Barry M. Weintraub as a prominent plastic surgeon ... beautiful women in the world, and the most handsome men, look naturally attractive. ...
Breaking Medicine News(10 mins):